HK1050134A1 - Hmg-coa reductase inhibitor extended release formulation. - Google Patents

Hmg-coa reductase inhibitor extended release formulation.

Info

Publication number
HK1050134A1
HK1050134A1 HK03100941A HK03100941A HK1050134A1 HK 1050134 A1 HK1050134 A1 HK 1050134A1 HK 03100941 A HK03100941 A HK 03100941A HK 03100941 A HK03100941 A HK 03100941A HK 1050134 A1 HK1050134 A1 HK 1050134A1
Authority
HK
Hong Kong
Prior art keywords
hmg
coa reductase
release formulation
extended release
reductase inhibitor
Prior art date
Application number
HK03100941A
Inventor
Chih-Ming Chen
Joseph Chou
David Wong
Original Assignee
Andrx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrx Corp filed Critical Andrx Corp
Publication of HK1050134A1 publication Critical patent/HK1050134A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
HK03100941A 1999-11-08 2003-02-07 Hmg-coa reductase inhibitor extended release formulation. HK1050134A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43557699A 1999-11-08 1999-11-08
PCT/US2000/030415 WO2001034123A1 (en) 1999-11-08 2000-11-03 Hmg-coa reductase inhibitor extended release formulation

Publications (1)

Publication Number Publication Date
HK1050134A1 true HK1050134A1 (en) 2003-06-13

Family

ID=23728948

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100941A HK1050134A1 (en) 1999-11-08 2003-02-07 Hmg-coa reductase inhibitor extended release formulation.

Country Status (8)

Country Link
AU (1) AU768950B2 (en)
CA (1) CA2390301A1 (en)
DE (1) DE10085183T1 (en)
GB (1) GB2371748B (en)
HK (1) HK1050134A1 (en)
IL (1) IL149524A0 (en)
NZ (1) NZ518770A (en)
WO (1) WO2001034123A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002244881A1 (en) * 2002-03-22 2003-10-08 Ranbaxy Laboratories Limited Controlled release drug delivery system of pravastatin
JP2006503023A (en) * 2002-09-03 2006-01-26 バイオヴェイル ラボラトリーズ インコーポレイテッド Pharmaceutical formulations and methods for modified release of statin drugs
US20090196889A1 (en) * 2004-11-22 2009-08-06 Dexcel Pharma Technologies Ltd. Controlled absorption of statins in the intestine
EP2079448A2 (en) * 2006-10-10 2009-07-22 Dexcel Pharma Technologies Ltd. Improved release of statins in the intestine
US9289418B2 (en) 2013-03-15 2016-03-22 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
CN105208861A (en) 2013-03-15 2015-12-30 雪松-西奈医学中心 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
KR102425303B1 (en) 2014-08-13 2022-07-25 세다르스-신나이 메디칼 센터 Anti-methanogenic compositions and uses thereof
US10736871B2 (en) 2015-04-01 2020-08-11 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US5244916A (en) * 1992-01-31 1993-09-14 The Scripps Research Institute Inhibition of respiratory burst using posttranslational modification inhibitors
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
IN176897B (en) * 1993-10-29 1996-09-28 Cadila Lab Ltd
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device

Also Published As

Publication number Publication date
GB0210619D0 (en) 2002-06-19
AU1360701A (en) 2001-06-06
WO2001034123A1 (en) 2001-05-17
AU768950B2 (en) 2004-01-08
GB2371748B (en) 2004-12-01
CA2390301A1 (en) 2001-05-17
IL149524A0 (en) 2002-11-10
DE10085183T1 (en) 2002-10-24
NZ518770A (en) 2004-02-27
GB2371748A (en) 2002-08-07

Similar Documents

Publication Publication Date Title
HUP0104258A3 (en) Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
ZA200210103B (en) HMG-CoA reductase inhibitors and method.
DK1223918T3 (en) Pharmaceutical compositions comprising an HMG-CoA reductase inhibitor
HK1046278A1 (en) Pyrazolobenzodiazepines as cdk2 inhibitors.
MXPA02005067A (en) Inhibitor compositions.
AU3155501A (en) Spreading factor determination
EP1286702A4 (en) HMG CoA REDUCTASE INHIBITORS FOR PROMOTING ANGIOGENESIS
AU2002310798A1 (en) Pharmaceutical compositions comprising a hmg-coa reductase inhibitor
AU2003250172A1 (en) Compositions comprising hmg-coa reductase inhibitor
AU1132601A (en) Feature interactions
PL354979A1 (en) Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
IL132786A0 (en) Hmg-coa reductase inhibitor preparation process
HK1050134A1 (en) Hmg-coa reductase inhibitor extended release formulation.
ZA200110053B (en) Factor via inhibitors.
AU3235100A (en) Prothease inhibitors
AU5670201A (en) Transceiver
AU3761400A (en) Amino-thio-acrylonitriles as mek inhibitors
AU2001290074A1 (en) Metal detector
AU3595900A (en) Tyrosine alkoxyguanidines as integrin inhibitors
AU5762899A (en) Caspase inhibitor
AU7887100A (en) Corrosion inhibitor
HUP0105145A3 (en) Process for producing hmg-coa reductase inhibitor
HUP0201597A2 (en) Antilipemic combunations comprising hmg-coa reductase inhibitors and carnitines
AU2001228647A1 (en) Dihydrofolate reductase inhibitors
HUP0301728A3 (en) Hmg-coa reductase inhibiting pharmaceutical compositions and their use

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20201102